BIM
FATE icon

BlackRock Investment Management’s Fate Therapeutics FATE Stock Holding History

BlackRock Investment Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$12K Hold
4,596
– – ﹤0.01% 3537
2016
Q3 		$14K Buy
4,596
+269
+6% +$653 ﹤0.01% 3463
2016
Q2 		$7K Hold
4,327
– – ﹤0.01% 3757
2016
Q1 		$8K Hold
4,327
– – ﹤0.01% 3692
2015
Q4 		$15K Hold
4,327
– – ﹤0.01% 3522
2015
Q3 		$23K Buy
4,327
+242
+6% +$1.65K ﹤0.01% 3394
2015
Q2 		$26K Buy
4,085
+1,906
+87% +$11.4K ﹤0.01% 3374
2015
Q1 		$11K Sell
2,179
-69
-3% -$342 ﹤0.01% 3613
2014
Q4 		$11K Hold
2,248
– – ﹤0.01% 3636
2014
Q3 		$11K Buy
2,248
+175
+8% +$1.01K ﹤0.01% 3626
2014
Q2 		$13K Buy
+2,073
New +$14.6K ﹤0.01% 3537

Other funds holding FATE

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return